130658-13-8 Usage
General Description
TERT-BUTYL 6-HYDROXY-HEXAHYDROCYCLOPENTA[C]PYRROLE-2(1H)-CARBOXYLATE is a chemical compound with the molecular formula C16H27NO3. It is a carboxylate ester derivative of 6-hydroxy-hexahydrocyclopenta[c]pyrrole-2(1H). TERT-BUTYL 6-HYDROXY-HEXAHYDROCYCLOPENTA[C]PYRROLE-2(1H)-CARBOXYLATE is commonly used as a building block in the synthesis of pharmaceuticals and other organic compounds. Its unique structure and functional groups make it a valuable reagent in the field of organic chemistry. However, it is important to handle this compound with care as it may be hazardous if not properly managed.
Check Digit Verification of cas no
The CAS Registry Mumber 130658-13-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,0,6,5 and 8 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 130658-13:
(8*1)+(7*3)+(6*0)+(5*6)+(4*5)+(3*8)+(2*1)+(1*3)=108
108 % 10 = 8
So 130658-13-8 is a valid CAS Registry Number.
InChI:InChI=1/C12H21NO3/c1-12(2,3)16-11(15)13-6-8-4-5-10(14)9(8)7-13/h8-10,14H,4-7H2,1-3H3
130658-13-8Relevant articles and documents
ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4
-
Paragraph 00221, (2019/05/22)
Disclosed herein are substituted hexahydro-1H-cyclopenta[c]pyrrole compounds, which may be useful as antagonists of the muscarinic acetylcholine receptor M4 (mAChR M4). Also disclosed herein are methods of making the compounds, pharmaceutical compositions comprising the compounds, and methods of treating disorders using the compounds and compositions.
N-ALKYL-AZACYCLOALKYL NMDA/NR2B ANTAGONISTS
-
, (2008/06/13)
Compounds represented by Formula (I): and/or pharmaceutically acceptable salts, individual enantiomers and stereoisomers thereof, are effective as NMDA/NR2B antagonists useful for treating conditions such as pain, Parkinson’s disease, Alzheimer’s disease, epilepsy, depression, anxiety, ischemic brain injury including stroke.
